Stocks · Healthcare · Biotechnology
Fractyl Health, Inc. GUTS
$0.41 -9.66% Close, Oct 2, 2026 · NASDAQ · Market cap $64.5M
Weak trendExpensive vs sectorHigh risk
Next earnings report: Nov 11, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The diluted share count rose 217.8% in a year.
- The stock is 83% below its highest close of the past year.
- Over the past year the stock returned -72.3%, behind the S&P 500 by 87.4 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 2%
- Revenue growth accelerationTop 46%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 8%
- Accruals (lower is better)Top 8%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 2%
- Free-cash-flow yieldBottom 2%
- EBITDA / enterprise valueBottom 3%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 6%
- 6-month returnBottom 31%
- 1-year return vs S&P 500Bottom 2%
- Distance from 52-week highBottom 2%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 35%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 34%
- Upside to consensus price targetTop 1%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 12%
- Maximum drawdown, 3 yearsBottom 3%
- Beta vs S&P 500 (lower is better)Top 35%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -100.0% | -100.0% | → |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -100.0% | -100.0% | → | Bottom 2% |
| Return on invested capital | -120.3% | — | Bottom 8% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -28.3%
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -167.07%
- Shareholder yield
- -167.07%
- Share count change, 1 year
- +217.8%
- Share count change, 3-year CAGR
- +49.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -3.8%
- Average 2-day reaction, last 8
- -1.0%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $5.00
- Target vs current price
- +1129.7%
- Analysts with a rating
- 3
- Share rating Buy or Strong Buy
- 67%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | +11.1% | -3.5% | -2.8% | -0.4% | — |
| May 12, 2026 | +135.3% | -4.6% | +4.9% | -13.6% | -10.7% |
| Mar 24, 2026 | -52.6% | -3.5% | -4.2% | +29.0% | +90.6% |
| Nov 12, 2025 | -108.8% | +2.7% | +27.3% | +112.7% | -60.9% |
| Aug 12, 2025 | -43.2% | +0.7% | +3.4% | -0.5% | +14.6% |
| May 13, 2025 | +0.0% | +3.5% | +24.0% | +26.3% | -43.1% |
| Mar 3, 2025 | -18.2% | +0.0% | -9.6% | -20.5% | +25.0% |
| Nov 12, 2024 | +4.0% | -3.2% | -17.9% | +0.4% | -40.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.12 | -$0.14 | +11.1% | — |
| May 12, 2026 | $0.06 | -$0.17 | +135.3% | — |
| Mar 24, 2026 | -$0.29 | -$0.19 | -52.6% | — |
| Nov 12, 2025 | -$0.71 | -$0.34 | -108.8% | — |
| Aug 12, 2025 | -$0.53 | -$0.37 | -43.2% | — |
| May 13, 2025 | -$0.49 | -$0.49 | +0.0% | — |
| Mar 3, 2025 | -$0.52 | -$0.44 | -18.2% | $3,000 |
| Nov 12, 2024 | -$0.48 | -$0.50 | +4.0% | $14,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| Free-cash-flow yield | -127.80% | — | — | Bottom 2% |
| Earnings yield | -270.54% | — | — | Bottom 2% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -12.5%
- 200-day average slope (20 days)
- -12.6%
- Distance from 50-day average
- -37.3%
- Distance from 200-day average
- -52.2%
- RSI (14)
- 29.9
- Relative volume
- 1.70×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 91.4%
- Volatility vs own 5-year history
- 38th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.87
- Correlation with S&P 500
- 0.12
- Current drawdown from 1-year high
- -82.8%
- Maximum drawdown, 3 years
- -96.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 2, 2024 | Feb 17, 2026 | -96.9% | 510 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $64.5M
- EPS, diluted (TTM)
- -$1.10
- Revenue (TTM)
- $0
- 52-week range
- $0.38 – $2.44
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $120,000 | $93,000 | $0 |
| Gross profit | $0 | -$452,000 | $43,000 | $43,000 | $0 |
| Operating income | -$36.9M | -$49.4M | -$50.8M | -$93.5M | -$96.8M |
| Net income | -$38.7M | -$46.5M | -$77.1M | -$68.7M | -$141.0M |
| EPS (diluted) | -$1.12 | -$1.34 | -$1.98 | -$1.62 | -$0.92 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14,000 | $3,000 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$23.2M | -$25.0M | -$23.7M | -$27.9M | -$45.6M | -$43.7M | $9.2M | -$25.5M |
| EPS (diluted) | -$0.48 | -$0.51 | -$0.49 | -$0.56 | -$0.71 | -$0.29 | $0.06 | -$0.16 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$33.5M | -$46.2M | -$42.8M | -$65.5M | -$90.3M |
| Capital expenditure | -$51,000 | -$56,000 | -$359,000 | -$1.8M | -$557,000 |
| Free cash flow | -$33.5M | -$46.3M | -$43.2M | -$67.3M | -$90.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $0 | $321,000 | $0 | $103.7M | $105.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $47.1M
- Total assets
- $82.0M
- Total liabilities
- $83.6M
- Total debt
- $60.7M
- Net debt
- $13.6M
- Shareholders’ equity
- -$1.7M
As of Jun 30, 2026 (filed Aug 10, 2026).
Short interest
- Shares sold short
- 2,696,513
- Days to cover
- 1.51
- Change vs previous report
- +21.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Oct 5, 2026
- 1-for-12